Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Buy
64
SMIZF Quote, Financials, Valuation and Earnings
Last price:
$7.79
Seasonality move
:
10.58%
Day range:
$7.79 - $7.79
52-week range:
$6.00 - $8.54
Dividend yield:
0%
P/E ratio:
11.20x
P/S ratio:
0.79x
P/B ratio:
2.49x
Volume:
--
Avg. volume:
3
1-year change:
26.26%
Market cap:
$1.7B
Revenue:
$2.1B
EPS (TTM):
$0.70
Analysts' Opinion
-
Consensus RatingMelia Hotels International SA has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, Melia Hotels International SA has an estimated downside of -- from its current price of $7.79.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $7.79.
Fair Value
-
According to the consensus of 0 analysts, Melia Hotels International SA has -- downside to fair value with a price target of -- per share.
SMIZF vs. S&P 500
-
Over the past 5 trading days, Melia Hotels International SA has underperformed the S&P 500 by -1.71% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Melia Hotels International SA does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Melia Hotels International SA has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Melia Hotels International SA reported revenues of $642.4M.
Earnings Growth
-
Melia Hotels International SA has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Melia Hotels International SA reported earnings per share of $0.37.
Enterprise value:
2.9B
EV / Invested capital:
--
Price / LTM sales:
0.79x
EV / EBIT:
8.86x
EV / Revenue:
1.33x
PEG ratio (5yr expected):
--
EV / Free cash flow:
8.25x
Price / Operating cash flow:
4.06x
Enterprise value / EBITDA:
4.91x
Gross Profit (TTM):
$1.9B
Return On Assets:
2.61%
Net Income Margin (TTM):
7.09%
Return On Equity:
21.69%
Return On Invested Capital:
6.11%
Operating Margin:
21.95%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $1.6B | $2B | $2.2B | $619M | $642.4M | |
| Gross Profit | $1.4B | $1.8B | $1.9B | $554.5M | $583.4M | |
| Operating Income | $45.2M | $232.9M | $322.4M | $112.3M | $141M | |
| EBITDA | $414.4M | $639.7M | $585.9M | $193.2M | $222.9M | |
| Diluted EPS | $0.09 | $0.74 | $0.70 | $0.26 | $0.37 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | -- | -- | -- | -- | |
| Current Liabilities | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -- | -- | -- | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2023-06-30 | 2024-06-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $184.7M | $521.2M | -- | $177.7M | $207.4M | |
| Cash From Investing | -- | -- | -- | -$63.5M | -$64.3M | |
| Cash From Financing | -- | -- | -- | -$113M | -$86M | |
| Free Cash Flow | $20.7M | $10.2M | $348.5M | $130.2M | $172.1M | |
SMIZF
Sector
Market Cap
$1.7B
$485.3M
Price % of 52-Week High
91.27%
72.18%
Dividend Yield
0%
0%
Shareholder Yield
--
3.59%
1-Year Price Total Return
26.26%
-12.14%
Beta (5-Year)
1.304
0.973
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
3.53%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$7.79
200-day SMA
Buy
Level
$7.44
Bollinger Bands (100)
Buy
Level
6.6 - 7.4
Chaikin Money Flow
Buy
Level
22K
20-day SMA
Buy
Level
$7.42
Relative Strength Index (RSI14)
Buy
Level
99.04
ADX Line
Neutral
Level
Williams %R
Sell
Level
0
50-day SMA
Buy
Level
$7.23
MACD (12, 26)
Buy
Level
0.19
25-day Aroon Oscillator
Buy
Level
64
On Balance Volume
Neutral
Level
18.9K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.428)
Sell
CA Score
(Annual)
Level (-1.8437)
Buy
Beneish M-Score
(Annual)
Level (-2.3033)
Buy
Momentum Score
Level (7)
Sell
Ohlson Score
Level (2.2574)
Buy
Piotroski F Score
(Annual)
Level (9)
Buy
Quality Ratio Score
Level (8)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Melia Hotels International SA is a Spanish owner and operator of hotels. The company operates midscale, upscale, and premium hotels across several brands, including Sol Hotels & Resorts, Melia Hotels & Resorts, and Gran Melia. Melia may either own or lease the hotels it operates, and hotel operation contributes the majority of company revenue. In addition, hotel owners may operate hotels under a Melia brand in a franchise agreement, or can contract Melia's management services to operate the hotel on its behalf. The company generates approximately half of its revenue in Spain, and the rest from America and the EMEA region.
Stock Forecast FAQ
In the current month, SMIZF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SMIZF average analyst price target in the past 3 months is --.
-
Where Will Melia Hotels International SA Stock Be In 1 Year?
According to analysts, the consensus estimate is that Melia Hotels International SA share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Melia Hotels International SA?
Analysts are divided on their view about Melia Hotels International SA share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Melia Hotels International SA is a Sell and believe this share price will rise from its current level to --.
-
What Is Melia Hotels International SA's Price Target?
The price target for Melia Hotels International SA over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is SMIZF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Melia Hotels International SA is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of SMIZF?
You can purchase shares of Melia Hotels International SA via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Melia Hotels International SA shares.
-
What Is The Melia Hotels International SA Share Price Today?
Melia Hotels International SA was last trading at $7.79 per share. This represents the most recent stock quote for Melia Hotels International SA. Yesterday, Melia Hotels International SA closed at $7.79 per share.
-
How To Buy Melia Hotels International SA Stock Online?
In order to purchase Melia Hotels International SA stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Sell
40
MSTR alert for Dec 24
MicroStrategy [MSTR] is up 8.12% over the past day.
Sell
26
NUTX alert for Dec 24
Nutex Health [NUTX] is down 0.82% over the past day.
Sell
48
VRNA alert for Dec 24
Verona Pharma PLC [VRNA] is down 0.35% over the past day.
